Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
Background: Acyclovir represents the first-line prophylaxis and therapy for herpes virus infections. However, its pharmacokinetics in children exposes them to the risk of ineffective or toxic concentrations. The study was aimed at investigating the population pharmacokinetics (POP/PK) of intravenous...
Main Authors: | Natalia Maximova, Daniela Nisticò, Giacomo Luci, Roberto Simeone, Elisa Piscianz, Ludovica Segat, Egidio Barbi, Antonello Di Paolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.865871/full |
Similar Items
-
Development of solid lipid nanoparticles for oral delivery of acyclovir and evaluation of its pharmacokinetics profile
by: Hassan, Haniza
Published: (2018) -
Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity
by: Abdullah M. Al-Alawi, et al.
Published: (2022-06-01) -
Vitreous pharmacokinetics and electroretinographic findings after intravitreal injection of acyclovir in rabbits
by: Francisco Max Damico, et al.
Published: (2012-08-01) -
Intraosseous infusion of acyclovir in a neonate
by: Saverio De Marca, et al.
Published: (2022-09-01) -
In vitro evaluation of cutaneous penetration of acyclovir from semisolid commercial formulations and relation with its effective antiviral concentration
by: Rafaela Martins Sponchiado, et al.